Race for Dengue vaccine intensifies as virus hits US for first time in 65 years

US drug companies are working hard to develop a vaccine for Dengue fever, which is endemic in Maldives. Sanofi Pasteur Inc. predicts the market for a vaccine is worth up to US$1 billion per year. Dengue has now re-emerged in Florida where 28 people have been diagnosed with the disease.